BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15763641)

  • 1. Hormonal therapy of endometrial cancer.
    Markman M
    Eur J Cancer; 2005 Mar; 41(5):673-5. PubMed ID: 15763641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal treatment of endometrial carcinoma.
    Baekelandt M
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):106-12. PubMed ID: 12113059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
    Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal therapies and gynaecological cancers.
    Garrett A; Quinn MA
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):407-21. PubMed ID: 17884734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The mechanisms of progesterone treatment on endometrial carcinoma].
    Chen C; Hua Z; Jin X
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):415-7. PubMed ID: 9639728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to chemotherapy and hormone therapy in endometrial cancer.
    Chaudhry P; Asselin E
    Endocr Relat Cancer; 2009 Jun; 16(2):363-80. PubMed ID: 19190080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal therapy of endometrial stromal sarcoma.
    Reich O; Regauer S
    Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
    Gadducci A; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA; Hartzfeld KM; Del Priore G
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data.
    Polyzos NP; Pavlidis N; Paraskevaidis E; Ioannidis JP
    Eur J Cancer; 2006 Feb; 42(3):319-26. PubMed ID: 16376072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy in metastatic or recurrent endometrial cancer.
    Pectasides D; Pectasides E; Economopoulos T
    Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of endometrial cancer.
    Barrena Medel NI; Bansal S; Miller DS; Wright JD; Herzog TJ
    Expert Opin Pharmacother; 2009 Aug; 10(12):1939-51. PubMed ID: 19586421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature.
    Dhar KK; NeedhiRajan T; Koslowski M; Woolas RP
    Gynecol Oncol; 2005 Jun; 97(3):924-7. PubMed ID: 15943993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with stage 1a endometrial carcinoma in whom a solitary recurrent lesion was detected in the external iliac lymph node after MPA therapy.
    Takahashi N; Hirashima Y; Harashima S; Takekuma M; Kawaguchi R; Yamada Y; Ito I
    Arch Gynecol Obstet; 2008 Oct; 278(4):365-7. PubMed ID: 18273628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report.
    Alkasi O; Meinhold-Heerlein I; Zaki R; Fasching P; Maass N; Jonat W; Beckmann MW
    Arch Gynecol Obstet; 2009 Jan; 279(1):57-60. PubMed ID: 18379806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospects for using aromatase inhibitors in treating endometrial cancer patients].
    Bochkareva NV; Kolomiets LA
    Vopr Onkol; 2001; 47(5):557-61. PubMed ID: 11785095
    [No Abstract]   [Full Text] [Related]  

  • 18. Leuprolide in the treatment of endometrial cancer.
    Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
    Gynecol Oncol; 1997 Sep; 66(3):542. PubMed ID: 9299275
    [No Abstract]   [Full Text] [Related]  

  • 19. Endometrial Cancer: Obesity, Genetics, and Targeted Agents.
    McDonald ME; Bender DP
    Obstet Gynecol Clin North Am; 2019 Mar; 46(1):89-105. PubMed ID: 30683268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
    Wang HY; Shen L; Sun Z
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.